Magnetic resonance imaging (MRI) of inflammation in stroke

Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings

Volumn , Issue , 2007, Pages 4316-4319

  Wiart, Marlène ^a   Davoust, Nathalie ^b   Pialat, Jean Baptiste ^a   Berthezène, Yves ^a   Nighoghossian, Norbert ^a  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IRON OXIDES; MACROPHAGES; NANOPARTICLES; PHYSIOLOGICAL MODELS;

INFLAMMATION; ISCHEMIC STROKE THERAPEUTICS; MAGNETIC LABELING;

MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIUM; FERRIC ION; FERRIC OXIDE; NANOPARTICLE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA;

ANIMAL; ARTICLE; BRAIN; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DISEASE MODEL; GENETICS; INFLAMMATION; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RADIOGRAPHY;

ANIMALS; BRAIN ISCHEMIA; CEREBRUM; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; FERRIC COMPOUNDS; INFLAMMATION; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MICE; MICE, KNOCKOUT; NANOPARTICLES; PPAR ALPHA; PPAR-BETA; STROKE;

EID: 57649235552     PISSN: 05891019     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/IEMBS.2007.4353291     Document Type: Conference Paper

References (27)

1. M. Fisher, A. Davalos, A. Rogalewski, A. Schneider, E. B. Ringelstein, and W.-R. Schabitz, "Toward a Multimodal Neuroprotective Treatment of Stroke," Stroke, vol. 37, pp. 1129-1136, 2006.
2. M. Kohrmann, E. Juttler, J. B. Fiebach, H. B. Huttner, S. Siebert, C. Schwark, P. A. Ringleb, P. D. Schellinger, and W. Hacke, "MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study," Lancet Neurol, vol. 5, pp. 661-7, 2006.
3. F. C. Barone and G. Z. Feuerstein, "Inflammatory mediators and stroke: new opportunities for novel therapeutics," J Cereb Blood Flow Metab, vol. 19, pp. 819-34., 1999.
4. Y. Ziv, A. Finkelstein, Y. Geffen, J. Kipnis, I. Smirnov, S. Shpilman, I. Vertkin, M. Kimron, A. Lange, T. Hecht, K. G. Reyman, J. B. Marder, M. Schwartz, and E. Yoles, "A novel immune-based therapy for stroke induces neuroprotection and supports neurogenesis," Stroke, vol. 38, pp. 774-82, 2007.
5. M. Schroeter, C. Franke, G. Stoll, and M. Hoehn, "Dynamic changes of magnetic resonance imaging abnormalities in relation to inflammation and glial responses after photothrombotic cerebral infarction in the rat brain," Acta Neuropathol (Berl), vol. 101, pp. 114-22, 2001.
6. J. B. Pialat, T. H. Cho, O. Beuf, S. Moucharrafie, J. B. Langlois, C. Nemoz, M. Janier, Y. Berthezene, N. Nighoghossian, B. Desvergne, and M. Wiart, "MRI monitoring of focal cerebral ischemia in peroxisome proliferator-activated receptor (PPAR)-deficient mice," NMR biomed, vol. 20, pp. (in press), 2007.
7. G. H. Simon, J. von Vopelius-Feldt, Y. Fu, J. Schlegel, G. Pinotek, M. F. Wendland, M. H. Chen, and H. E. Daldrup-Link, "Ultrasmali supraparamagnetic iron oxide-enhanced magnetic resonance imaging of antigen-induced arthritis: a comparative study between SHU 555 C, ferumoxtran-10, and ferumoxytol," Invest Radiol, vol. 41, pp. 45-51, 2006.
8. V. Dousset, B. Brochet, M. S. Deloire, L. Lagoarde, B. Barroso, J. M. Caille, and K. G. Petry, "MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium," AJNR Am J Neuroradiol, vol. 27, pp. 1000-5, 2006.
9. T. Tang, S. P. Howarth, S. R. Miller, R. Trivedi, M. J. Graves, J. U. King-Im, Z. Y. Li, A. P. Brown, P. J. Kirkpatrick, M. E. Gaunt, and J. H. Gillard, "Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI," Stroke, vol. 37, pp. 2266-70, 2006.
10. H. E. Rice, E. W. Hsu, H. Sheng, D. A. Evenson, A. J. Freemerman, K. M. Safford, J. M. Provenzale, D. S. Warner, and G. A. Johnson, " Superparamagnetic iron oxide labeling and transplantation of adipose-derived stem cells in middle cerebral artery occlusion-injured mice," AJR Am J Roentgenol, vol. 188, pp. 1101-8, 2007.
11. C. Corot, P. Robert, J. M. Idee, and M. Port, "Recent advances in iron oxide nanocrystal technology for medical imaging," Adv Drug Deliv Rev, vol. 58, pp. 1471-504, 2006.
12. M. Rausch, A. Sauter, J. Frohlich, U. Neubacher, E. W. Radu, and M. Rudin, "Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage," Magn Reson Med, vol. 46, pp. 1018-22., 2001.
13. M. Rausch, D. Baumann, U. Neubacher, and M. Rudin, "In-vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO," NMR Biomed, vol. 15, pp. 278-83., 2002.
14. C. Kleinschnitz, M. Bendszus, M. Frank, L. Solymosi, K. V. Toyka, and G. Stoll, "In vivo monitoring of macrophage infiltration in experimental ischemic brain lesions by magnetic resonance imaging," J Cereb Blood Flow Metab, vol. 23, pp. 1356-61., 2003.
15. A. Saleh, D. Wiedermann, M. Schroeter, C. Jonkmanns, S. Jander, and M. Hoehn, "Central nervous system inflammatory response after cerebral infarction as detected by magnetic resonance imaging," NMR Biomed, vol. 17, pp. 163-9., 2004.
16. M. Schroeter, A. Saleh, D. Wiedermann, M. Hoehn, and S. Jander, "Histochemical detection of ultrasmall superparamagnetic iron oxide (USPIO) contrast medium uptake in experimental brain ischemia," Magn Reson Med, vol. 52, pp. 403-6., 2004.
17. M. Wiart, N. Davoust, J. B. Pialat, V. Desestret, S. Moucharaffie, T. H. Cho, M. Mutin, J. B. Langlois, O. Beuf, J. Honnorat, N. Nighoghossian, and Y. Berthezene, "MRI monitoring of neuroinflammation in mouse focal ischemia," Stroke, vol. 38, pp. 131-7, 2007.
18. M. Schroeter, S. Jander, O. W. Witte, and G. Stoll, "Heterogeneity of the microglial response in photochemically induced focal ischemia of the rat cerebral cortex," Neuroscience, vol. 89, pp. 1367-77., 1999.
19. A. Saleh, M. Schroeter, C. Jonkmanns, H. P. Hartung, U. Modder, and S. Jander, "In vivo MRI of brain inflammation in human ischaeinic stroke," Brain, vol. 127, pp. 1670-7., 2004.
20. N. Nighoghossian, M. Wiart, S. Cakmak, Y. Berthezene, L. Derex, T. H. Cho, C. Nemoz, F. Chapuis, G. L. Tisserand, J. B. Pialat, P. Trouillas, J. C. Froment, and M. Hermier, "Inflammatory response after ischemic stroke: a USPIO-enhanced MRI study in patients," Stroke, vol. 38, pp. 303-7, 2007.
21. W. J. Rogers, C. H. Meyer, and C. M. Kramer, "Technology insight: in vivo cell tracking by use of MRI," Nat Clin Pract Cardiovasc Med, vol. 3, pp. 554-62, 2006.
22. M. Bendszus, C. Kleinschnitz, and G. Stoll, "Iron-Enhanced MRI in Ischemic Stroke: Intravascular Trapping Versus Cellular Inflammation," Stroke, 2007.
23. M. Wiart, N. Davoust, V. Desestret, N. Nighoghossian, and Y. Berthezene, "Response to Letter by Bendszus et al," Stroke, 2007.
24. C. Kleinschnitz, A. Schutz, I. Nolte, T. Horn, M. Frank, L. Solymosi, G. Stoll, and M. Bendszus, "In vivo detection of developing vessel occlusion in photothrombotic ischemic brain lesions in the rat by iron particle enhanced MRI," J Cereb Blood Flow Metab, vol. 25, pp. 1548-55., 2005.
25. J. A. Gaasch, P. R. Lockman, W. J. Geldenhuys, D. D. Allen, and C. J. Van der Schyf, "Brain Iron Toxicity: Differential Responses of Astrocytes, Neurons, and Endothelial Cells," Neurochem Res, 2007.
26. G. H. Simon, J. Bauer, O. Saborovski, Y. Fu, C. Corot, M. F. Wendland, and H. E. Daldrup-Link, "T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning," Eur Radiol, pp. 1-8., 2005.
27. V. Mani, K. C. Briley-Saebo, V. V. Itskovich, D. D. Samber, and Z. A. Fayad, "Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T," Magn Reson Med, vol. 55, pp. 126-35, 2006.